Jinling Pharmaceutical Company Limited (000919.SZ)

CNY 6.91

(-1.14%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.55 Billion 4.54 Billion 4.44 Billion 4.28 Billion 4.15 Billion 3.88 Billion
Total Current Assets 2.31 Billion 2.63 Billion 2.28 Billion 2.04 Billion 2.24 Billion 2.24 Billion
Cash And Short Term Investments 1.51 Billion 1.58 Billion 1.5 Billion 1.31 Billion 1.57 Billion 1.01 Billion
Cash and Cash Equivalents 1.42 Billion 1.49 Billion 1.5 Billion 1.31 Billion 1.46 Billion 965.54 Million
Short Term Investments 82.56 Million 92.35 Million 1.25 Million 1.37 Million 110.28 Million 52.44 Million
Net Receivables 519.57 Million 515.12 Million 536.54 Million 504.08 Million 430.36 Million 581.65 Million
Inventory 268.06 Million 250.48 Million 245.47 Million 215.43 Million 233.98 Million 236.54 Million
Other Current Assets 4.81 Million 280.16 Million 3.8 Million 10.57 Million 5.35 Million 412.68 Million
Total Non-Current Assets 2.23 Billion 1.91 Billion 2.15 Billion 2.23 Billion 1.91 Billion 1.63 Billion
Net PPE 1.31 Billion 1.3 Billion 1.29 Billion 1.3 Billion 1.13 Billion 1.11 Billion
Good Will And Intangible Assets 294.3 Million 285.77 Million 158.24 Million 212.19 Million 266 Million 365.28 Million
Good Will 27.33 Million 27.33 Million 18.04 Million 64.01 Million 109.6 Million 198.02 Million
Intangible Assets 266.97 Million 258.44 Million 140.19 Million 148.18 Million 156.39 Million 167.25 Million
Long-Term Investments 271.04 Million 172.66 Million 387.71 Million 422.99 Million 365.88 Million 58.58 Million
Tax Assets 11.05 Million 27.58 Million 19.62 Million 14.95 Million 16.77 Million 16.45 Million
Other Non Current Assets 337.27 Million 122.87 Million 297.88 Million 281.32 Million 131.19 Million 79.56 Million
Other Assets -0.00 1.00 - - 1.00 -
Total Liabilities 865.57 Million 916.29 Million 913.09 Million 850.42 Million 733.62 Million 638.89 Million
Total Current Liabilities 839.89 Million 865.41 Million 855.95 Million 799.57 Million 677.33 Million 608.11 Million
Account Payables 431.59 Million 454.04 Million 479.36 Million 465.78 Million 336.28 Million 240.61 Million
Tax Payables 30.05 Million 58.3 Million 53.1 Million 45.2 Million 41.1 Million 57.56 Million
Short Term Debt 2.26 Million 3.01 Million 16.07 Million 38.73 Million 31.92 Million 29.91 Million
Deferred Revenue 402.77 Million 23.77 Million 357.34 Million 32.58 Million 29.64 Million 26.29 Million
Other Current Liabilities 3.25 Million 384.59 Million 3.17 Million 262.47 Million 279.48 Million 311.28 Million
Total Non Current Liabilities 25.67 Million 50.88 Million 57.14 Million 50.85 Million 56.28 Million 30.78 Million
Long-Term Debt 2.54 Million 2.28 Million 589.23 Thousand 1.12 Million - -
Deferred Revenue Non Current 467.53 Thousand 626.97 Thousand 786.42 Thousand 1.27 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 1.00 1.00 -1.12 Million - -
Other Liabilities 1.00 - 1.00 - - -
Total Equity 3.68 Billion 3.62 Billion 3.53 Billion 3.43 Billion 3.42 Billion 3.24 Billion
Stock Holders Equity 3.04 Billion 2.99 Billion 2.92 Billion 2.85 Billion 2.87 Billion 2.73 Billion
Common Stock 511.13 Million 510.4 Million 504 Million 504 Million 504 Million 504 Million
Retained Earnings 1.66 Billion 1.62 Billion 1.57 Billion 1.5 Billion 1.53 Billion 1.41 Billion
Accumulated other comprehensive income 3.42 Million 380.16 Million 390.47 Million 383.08 Million 378.44 Million 364.04 Million
Common Stock Equity 3.04 Billion 2.99 Billion 2.92 Billion 2.85 Billion 2.87 Billion 2.73 Billion
Capital Lease Obligation 2.54 Million 2.28 Million 589.23 Thousand 1.12 Million - -
Total Investments 271.04 Million 265.01 Million 388.97 Million 424.37 Million 476.16 Million 111.03 Million
Total Debt 4.81 Million 5.29 Million 16.66 Million 39.85 Million 31.92 Million 29.91 Million
Net Debt -1.42 Billion -1.48 Billion -1.48 Billion -1.27 Billion -1.43 Billion -935.62 Million

Balance Sheet Charts